User profiles for T. R. Mikuls

Ted Mikuls

Stokes Shackleford Professor of Rheumatology, University of Nebraska Medical Center
Verified email at unmc.edu
Cited by 26192

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

BR England, GM Thiele, DR Anderson, TR Mikuls - Bmj, 2018 - bmj.com
Rheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity
and mortality from cardiovascular disease. Mechanisms linking rheumatoid arthritis and …

Co-morbidity in rheumatoid arthritis

TR Mikuls - Best practice & research Clinical rheumatology, 2003 - Elsevier
Rheumatoid arthritis (RA) affects approximately 0.5–1% of the population and imposes
substantial societal costs including an increased risk of work-related disability and accelerated …

Quality of care indicators for gout management

TR Mikuls, CH MacLean, J Olivieri… - Arthritis & …, 2004 - Wiley Online Library
Objective Despite the significant health impact of gout, there is no consensus on management
standards. To guide physician practice, we sought to develop quality of care indicators for …

[HTML][HTML] Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis

SR Ytterberg, DL Bhatt, TR Mikuls… - … England Journal of …, 2022 - Mass Medical Soc
Background Increases in lipid levels and cancers with tofacitinib prompted a trial of major
adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis …

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

LA Merlino, J Curtis, TR Mikuls… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Vitamin D is a potent regulator of calcium homeostasis and may have immunomodulatory
effects. The influence of vitamin D on human autoimmune disease has not been well …

Gout epidemiology: results from the UK general practice research database, 1990–1999

TR Mikuls, JT Farrar, WB Bilker, S Fernandes… - Annals of the …, 2005 - ard.bmj.com
TR Mikuls1, … Farrar J, Mikuls T, Saag K, Bilker W, Fernandes S, Strom B. Issues in the
determination of disease prevalence from medical record databases: cumulative incidence in …

American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2

…, AS Turner, EA Williams, TR Mikuls - Arthritis & …, 2021 - Wiley Online Library
Mikuls has received consulting fees, speaking fees, and/or honoraria from Sanofi, Horizon,
Pfizer, and Gilead (less than $10,000 each) and research support from Bristol Myers Squibb …

Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase

…, R Wait, P Charles, TR Mikuls… - … : Official Journal of …, 2008 - Wiley Online Library
Mikuls has received consulting fees, speaking fees, and/or honoraria from Amgen,
Genentech, and Bristol-Myers Squibb (less than $10,000 each). Patent applications (GB0701417.8 …

[PDF][PDF] Periodontitis and Porphyromonas gingivalis in Patients With Rheumatoid Arthritis

TR Mikuls, JB Payne, F Yu, GM Thiele… - Arthritis & …, 2014 - Wiley Online Library
Mikuls had full access to all of the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis. Study conception and design. …

[HTML][HTML] Therapies for active rheumatoid arthritis after methotrexate failure

JR O'Dell, TR Mikuls, TH Taylor… - … England Journal of …, 2013 - Mass Medical Soc
Background Few blinded trials have compared conventional therapy consisting of a
combination of disease-modifying antirheumatic drugs with biologic agents in patients with …